David S. Schilansky

David S. Schilansky

Founder chez One Biosciences SAS

48 ans
Health Technology
Consumer Services
Producer Manufacturing

Profil

Founder of One Biosciences SAS and Home Biosciences SAS, David S.
Schilansky
is Chairman & Chief Executive Officer for Home Biosciences SAS and Chairman for One Biosciences SAS (a subsidiary of Home Biosciences SAS).
Mr. Schilansky previously occupied the position of Chief Operating & Financial Officer for DBV Technologies SA, Group Chief Financial Officer for Ipsen SA Chief Financial Officer for Ipsen Pharma SAS and Head-Investor Relations at Tercica, Inc. (both are subsidiaries of Ipsen SA), Manager-Investor Relations for Ipsen International GmbH and Head-Investor Relations at Technicolor USA, Inc. Mr. Schilansky received a graduate degree from Université Paris Dauphine-PSL and a graduate degree from Imperial College London.

Postes actifs de David S. Schilansky

SociétésPosteDébut
Founder 01/07/2020
Chief Executive Officer 01/01/2019
Tous les postes actifs de David S. Schilansky

Anciens postes connus de David S. Schilansky

SociétésPosteFin
LYSOGENE Director/Board Member 24/06/2022
DBV TECHNOLOGIES Director of Finance/CFO -
IPSEN Director of Finance/CFO 01/12/2011
Investor Relations Contact -
Director of Finance/CFO -
Voir l'expérience en détail de David S. Schilansky

Formation de David S. Schilansky

Imperial College London Graduate Degree
Université Paris Dauphine-PSL Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David S. Schilansky

Relations

70

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
IPSEN

Health Technology

DBV TECHNOLOGIES

Health Technology

LYSOGENE

Commercial Services

Entreprise privées6

Health Technology

Producer Manufacturing

Consumer Durables

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David S. Schilansky